Spondyloarthritis & psoriatic arthritis

Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study

Rheumatology (Oxford)Published Longitudinal cohort study

Authors' conclusion

The overall incidence of DD in this SpA cohort was low. Incident DD was higher in axSpA than in PsA. A diagnosis of axSpA, the presence of IBD, and ever-smoking predicted the development of DD. History of TNF-α inhibitor use was not found to be a predictor of DD in this cohort.

Study context

Population
Axial SpA (axSpA) and PsA patients from a longitudinal cohort databasewith follow-up data
Participants
2,260 participants
Exposure
axSpA vs PsA; predictors of demyelinating disease (DD)
Outcome
Incidence of demyelinating disease (DD)
Methodological detailscompeting risk analysis, Cox regression (Fine and Gray's method)
  • Competing risk analysis
  • Cox regression (Fine and Gray's method)

Main finding

As reported in the abstract

Incidence of DD

DD events

18

Average IR of DD in SpA, per 100 000 persons per year

31

Observational data: associations, not effects.

Further findings

Incidence rate of DD at 20 years · competing risk analysis

P = 0.01

OutcomeHR (95% CI)P value
Predictors of DD development (best predictive model)Ever-smokingvs Never-smokingCox regression with Fine and Gray's method2.918 (1.037–8.214)P = 0.0426
Predictors of DD development (best predictive model)axSpAvs PsACox regression with Fine and Gray's method8.790 (1.242–62.182)P = 0.0294
Predictors of DD development (best predictive model)Presence of IBDvs Absence of IBDCox regression with Fine and Gray's method5.698 (2.083–15.589)P = 0.0007

Predictors of DD development (best predictive model)

History of TNF-α inhibitor therapy was not a predictor of DD

Original publication

Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study. Rheumatology (Oxford). Published 4 October 2023. doi:10.1093/rheumatology/kead527

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.